Causal effects of serum metabolites on amyotrophic lateral sclerosis: A Mendelian randomization study
- 24 October 2019
- journal article
- research article
- Published by Elsevier BV in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 97, 109771
- https://doi.org/10.1016/j.pnpbp.2019.109771
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81071952)
This publication has 44 references indexed in Scilit:
- Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discoveryProteomics – Clinical Applications, 2013
- Genome-wide association study identifies multiple loci influencing human serum metabolite levelsNature Genetics, 2012
- Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALSAmyotrophic Lateral Sclerosis, 2012
- KEGG for integration and interpretation of large-scale molecular data setsNucleic Acids Research, 2011
- Amyotrophic lateral sclerosisThe Lancet, 2011
- Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association studyThe Lancet Neurology, 2010
- Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variantsInternational Journal of Epidemiology, 2010
- Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human SerumPLoS Genetics, 2008
- Aγ-Glutamyl Transpeptidase-Independent Pathway of Glutathione Catabolism to Glutamate via 5-Oxoproline in ArabidopsisPlant Physiology, 2008
- Intermediates of the gamma-Glutamyl Cycle in Mouse Tissues. Influence of Administration of Amino Acids on Pyrrolidone Carboxylate and gamma-Glutamyl Amino AcidsJBIC Journal of Biological Inorganic Chemistry, 1975